{"id":"https://openalex.org/W2324674617","doi":"https://doi.org/10.7164/antibiotics.28.594","title":"Laboratory studies with cefatrizine (SK&F 60771) a new broad-spectrum orally-active cephalosporin.","display_name":"Laboratory studies with cefatrizine (SK&F 60771) a new broad-spectrum orally-active cephalosporin.","publication_year":1975,"publication_date":"1975-01-01","ids":{"openalex":"https://openalex.org/W2324674617","doi":"https://doi.org/10.7164/antibiotics.28.594","mag":"2324674617","pmid":"https://pubmed.ncbi.nlm.nih.gov/808525"},"language":"en","primary_location":{"id":"doi:10.7164/antibiotics.28.594","doi":"https://doi.org/10.7164/antibiotics.28.594","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.28.594","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/28/8/28_8_594/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/28/8/28_8_594/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009069306","display_name":"Paul Actor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"PAUL ACTOR","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081979456","display_name":"Joseph V. Uri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JOSEPH V. URI","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045692559","display_name":"Lillian Phillips","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"LILLIAN PHILLIPS","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054072863","display_name":"CARL S. SACHS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"CARL S. SACHS","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066418002","display_name":"Joseph R. Guarini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JOSEPH R. GUARINI","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":null,"display_name":"IHOR ZAJAC","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"IHOR ZAJAC","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035958995","display_name":"David A. Berges","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"DAVID A. BERGES","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036023887","display_name":"George L. Dunn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"GEORGE L. DUNN","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054904189","display_name":"John R. E. Hoover","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JOHN R. E. HOOVER","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076850339","display_name":"Jerry A. Weisbach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JERRY A. WEISBACH","raw_affiliation_strings":["Research and Development Division, Smith Kline & French Laboratories Philadelphia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development Division, Smith Kline & French Laboratories Philadelphia","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":4.019,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.9389881,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"28","issue":"8","first_page":"594","last_page":"601"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefatrizine","display_name":"cefatrizine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.8519999980926514},{"id":"https://openalex.org/keywords/antibacterial-activity","display_name":"antibacterial activity","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8870000243186951},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cephalexin","display_name":"cephalexin","score":0.9390000104904175},{"id":"https://openalex.org/keywords/cefazolin","display_name":"cefazolin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/escherichia-coli","display_name":"Escherichia coli","score":0.8309999704360962},{"id":"https://openalex.org/keywords/klebsiella-pneumoniae","display_name":"Klebsiella pneumoniae","score":0.9959999918937683},{"id":"https://openalex.org/keywords/enterobacter-cloacae","display_name":"Enterobacter cloacae","score":0.9729999899864197},{"id":"https://openalex.org/keywords/staphylococcus-aureus","display_name":"Staphylococcus aureus","score":0.9169999957084656},{"id":"https://openalex.org/keywords/haemophilus-influenzae","display_name":"Haemophilus influenzae","score":0.8790000081062317},{"id":"https://openalex.org/keywords/morganella-morganii","display_name":"Morganella morganii","score":0.9549999833106995},{"id":"https://openalex.org/keywords/mice","display_name":"mice","score":0.3050000071525574},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.9139999747276306},{"id":"https://openalex.org/keywords/squirrel-monkey","display_name":"squirrel monkey","score":0.9480000138282776},{"id":"https://openalex.org/keywords/rabbits","display_name":"rabbits","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2778353156","wikidata":"https://www.wikidata.org/wiki/Q415739","display_name":"Cefazolin","level":3,"score":0.821710467338562},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.6014063358306885},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5979277491569519},{"id":"https://openalex.org/C2777402170","wikidata":"https://www.wikidata.org/wiki/Q4038096","display_name":"Enterobacter cloacae","level":5,"score":0.5944781303405762},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5213212370872498},{"id":"https://openalex.org/C2778983983","wikidata":"https://www.wikidata.org/wiki/Q134281","display_name":"Enterobacter","level":4,"score":0.5086613297462463},{"id":"https://openalex.org/C2780662933","wikidata":"https://www.wikidata.org/wiki/Q2701588","display_name":"Proteus vulgaris","level":4,"score":0.46849068999290466},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4570179283618927},{"id":"https://openalex.org/C2777058267","wikidata":"https://www.wikidata.org/wiki/Q132592","display_name":"Klebsiella pneumoniae","level":4,"score":0.44277533888816833},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4199550449848175},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41441136598587036},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.39161473512649536},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34013086557388306},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.2012728750705719},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.10898241400718689},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08965593576431274},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000882","descriptor_name":"Haplorhini","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002437","descriptor_name":"Cefazolin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002506","descriptor_name":"Cephalexin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004926","descriptor_name":"Escherichia coli","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007711","descriptor_name":"Klebsiella pneumoniae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013211","descriptor_name":"Staphylococcus aureus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7164/antibiotics.28.594","doi":"https://doi.org/10.7164/antibiotics.28.594","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.28.594","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/28/8/28_8_594/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},{"id":"pmid:808525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/808525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antibiotics","raw_type":"Comparative Study"}],"best_oa_location":{"id":"doi:10.7164/antibiotics.28.594","doi":"https://doi.org/10.7164/antibiotics.28.594","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.28.594","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/28/8/28_8_594/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2324674617.pdf","grobid_xml":"https://content.openalex.org/works/W2324674617.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W1974772720","https://openalex.org/W2030962977","https://openalex.org/W2037230069","https://openalex.org/W2058647973","https://openalex.org/W2088034106","https://openalex.org/W2262090769","https://openalex.org/W2401188729"],"related_works":["https://openalex.org/W2326922054","https://openalex.org/W2092772606","https://openalex.org/W1551280252","https://openalex.org/W2166424096","https://openalex.org/W1993342294","https://openalex.org/W2087587026","https://openalex.org/W2413757823","https://openalex.org/W258274220","https://openalex.org/W1978184644","https://openalex.org/W2140810177"],"abstract_inverted_index":{"Cefatrizine":[0,75],"(SK&F":[1],"60771),":[2],"a":[3,61,77,82],"new":[4],"orally-active":[5],"semisynthetic":[6],"cephalosporin":[7],"antibiotic":[8],"with":[9,15,38,50,112],"broad-spectrum":[10],"antibacterial":[11,25],"activity,":[12],"was":[13,142,146],"compared":[14],"cephalexin":[16,51,91],"and":[17,22,27,42,52,67,81],"cefazolin":[18,89],"for":[19],"in":[20,23,30,105,109,131],"vitro":[21],"vivo":[24,106],"activity":[26,108],"pharmacokinetic":[28,129,137],"behavior":[29],"laboratory":[31],"animals.":[32],"The":[33],"average":[34],"MIC":[35],"values":[36],"obtained":[37,49],"cefatrizine":[39,145],"against":[40],"gram-positive":[41],"gram-negative":[43],"bacteria":[44],"were":[45,70],"superior":[46,128],"to":[47,72,97,152],"those":[48,56],"somewhat":[53],"poorer":[54],"than":[55,87],"of":[57,64],"cefazolin.":[58],"In":[59],"addition,":[60],"large":[62],"percentage":[63],"the":[65],"enterobacter":[66],"enterococcus":[68],"isolates":[69],"found":[71],"be":[73],"susceptible.":[74],"had":[76,103],"longer":[78],"biological":[79],"half-life":[80],"higher":[83],"peak":[84],"serum":[85],"level":[86],"either":[88,148],"or":[90,95,123,150,156],"when":[92,144],"administered":[93,147],"parenterally":[94,151],"orally":[96,149],"mice":[98,110],"at":[99],"20":[100],"mg/kg.":[101],"It":[102],"striking":[104],"protective":[107],"infected":[111],"Escherichia":[113],"coli,":[114],"Klebsiella":[115],"pneumoniae,":[116],"Enterobacter":[117],"cloacae,":[118],"Hemophilus":[119],"influenzae,":[120],"Proteus":[121],"morganii":[122],"Staphylococcus":[124],"aureus":[125],"reflecting":[126],"its":[127],"profile":[130],"this":[132],"animal":[133,140],"species.":[134],"A":[135],"variable":[136],"response":[138],"between":[139],"species":[141],"observed":[143],"dogs,":[153],"squirrel":[154],"monkeys":[155],"rabbits.":[157]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}